Stay updated with breaking news from Get Free. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price […]
Shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR – Get Free Report) have been assigned an average recommendation of “Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their […]
CVRx, Inc. (NASDAQ:CVRX – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among […]
Hargreaves Lansdown plc (LON:HL – Get Free Report) has received an average rating of “Hold” from the seven brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have issued a buy recommendation on the company. The […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]